What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...
Dr Robert DeBernardo explains how new immunotherapies are reshaping care and how their earlier availability might have ...
Side effects depend on treatment type, and it’s important to tell your healthcare provider if you notice any. “Patients should be familiar with what signs and symptoms to monitor and feel encouraged ...
Please provide your email address to receive an email when new articles are posted on . FDA drug approvals have led to significant advancement in endometrial cancer treatment. Stage and histology ...
Dr Dana Chase recalls early-career experiences and describes how revolutionary advances in surgery and personalized medicine ...
The current study looked at treatment data from 2 randomized trials conducted by the Women’s Health Initiative with long term follow up. The effects of MHT on incidence and mortality from ovarian ...
After receiving radiation therapy for uterine cancer, you may experience fertility challenges, vaginal dryness, and bowel or bladder problems. Options to manage and relieve your side effects can vary.
Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...
Study shows ctDNA positivity is the most prognostic factor, demonstrating the potential for Signatera to redefine adjuvant treatment pathways in endometrial cancer This real-world study analyzed 267 ...
The endometrial cancer market space will experience significant growth during the forecast period of 2025--2034. The future is brighter for patients with endometrial cancer. Targeted agents and ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results